percent of lung cancer patients have wild type EGFR, meaning there
is no EGFR mutation. Dr. Joan Schiller of UT Southwestern Medical
Center discusses a new drug in development that may help those
patients. February 2014
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.